Characterization of solid lipid nanoand microparticles

Lipospheres in Drug Targets and Delivery: Approaches, Methods, and Applications

Volumn , Issue , 2004, Pages 41-66

  Bunjes, Heike ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056344136     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203505281     Document Type: Chapter

References (116)

1. Bunjes H., Koch M.H.J., and Westesen K., Effect of particle size on colloidal solid triglycerides, Langmuir, 16, 5234, 2000.
2. Westesen K., Drechsler M., and Bunjes H., Colloidal dispersions based on solid lipids, in Food Colloids: Fundamentals of Formulation, Dickinson E. and Miller R., eds., Royal Society of Chemistry, Cambridge, 2001, 103.
3. Jores K. et al., Investigations on the structure of solid lipid nanoparticles (SLN) and oil loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy, J. Control. Rel., 95, 217, 2004.
4. Washington C., Photon correlation spectroscopy, in Particle Size Analysis in Pharmaceutics and Other Industries, Ellis Horwood, New York, 1992, 135.
5. Finsey R., Particle sizing by quasi-elastic light scattering, Adv. Colloid Interface Sci., 52, 79, 1994.
6. Allen T., Photon correlation spectroscopy, in Particle Size Measurement, Vol. 1, Allen T., ed., Chapman & Hall, London, 1997, 426.
7. Tscharnuter W., Photon correlation in particle sizing, in Encyclopedia of Analytical Chemistry, Meyers R.A., ed., Wiley, Chichester, 2000, 5469.
8. Koppel D.E., Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants, J. Chem. Phys., 57, 4814, 1972.
9. Gasco M.R., Cavalli R., and Carlotti M.E., Timolol in lipospheres, Pharmazie, 47, 119, 1992.
10. Cavalli R. et al., Study by x-ray powder diffraction and differential scanning calorimetry of two model drugs, phenothiazine and nifedipine, incorporated into lipid nanoparticles, Eur. J. Pharm. Biopharm., 41, 329, 1995.
11. Schwarz C. and Mehnert W., Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles, Int. J. Pharm., 157, 171, 1997.
12. Pellizzaro C. et al., Cholesteryl butyrate in solid lipid nanospheres as an alternative approach for butyric acid delivery, Anticancer Res., 19, 3921, 1999.
13. Santos Maia C., Mehnert W., and Schäfer-Korting M., Solid lipid nanoparticles as drug carriers for topical glucocorticoids, Int. J. Pharm., 196, 165, 2000.
14. Kristl J. et al., Effect of colloidal carriers on ascorbyl palmitate stability, Eur. J. Pharm. Sci., 19, 181, 2003.
15. Thomas J.C., The determination of log normal particle size distributions by dynamic light scattering, J. Colloid Interface Sci., 117, 187, 1987.
16. Siekmann B. and Westesen K., Submicron-sized parenteral carrier systems based on solid lipids, Pharm. Pharmacol. Lett., 1, 123, 1992.
17. Siekmann B. and Westesen K., Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol. II. Physicochemical characterization and lyophilization, Pharm. Pharmacol. Lett., 3, 225, 1994.
18. Siekmann B. and Westesen K., Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions, Eur. J. Pharm. Biopharm., 43, 104, 1996.
19. Unruh T. et al., Observation of size-dependent melting in lipid nanoparticles, J. Phys. Chem. B, 103, 10373, 1999.
20. Friedrich I. and Müller-Goymann C.C., Characterization of solidified reverse micellar solutions (SRMS) and production development of SRMS-based nanosuspensions, Eur. J. Pharm. Biopharm., 56, 111, 2003.
21. Cantor C.R. and Schimmel P.R., Biophysical Chemistry: Techniques for the Study of Biological Structure and Function, Part II, Freeman, New York, 1980, 539.
22. Perrin F., Mouvement Brownien d’un ellipsoide. II. Rotation libre et dépolarisation des fluorescences. Translation et diffusion de molécule ellipsoidales, J. Phys. Radium, 7, 1, 1936.
23. Washington C., The angular distribution of scattered light, in Particle Size Analysis in Pharmaceutics and Other Industries, Ellis Horwood, New York, 1992, 109.
24. Del Curto M.D. et al., Lipid microparticles as sustained release system for a GnRH antagonist (Antide), J. Control. Rel., 98, 297, 2003.
25. Erni, C. et al., Evaluation of cationic solid lipid microparticles as synthetic carriers for the targeted delivery of macromolecules to phagocytic antigen-presenting cells, Biomaterials, 23, 4667, 2002.
26. Frederiksen H.K., Kristensen H.G., and Pedersen M., Solid lipid microparticle formulations of the pyrethroid gamma-cyhalothrin-incompatibility of the lipid and the pyrethroid and biological properties of the formulations, J. Control. Rel., 86, 243, 2003.
27. Masters D.B. and Domb A.J., Liposphere local anesthetic timed-release for perineural site application, Pharm. Res., 15, 1038, 1998.
28. Wedd M.W., Particle sizing in the sub-micron range by laser diffraction, in Particle and Surface Characterization Methods, Müller R.H. and Mehnert W., eds., Scientific Publishers, Stuttgart, 1997, 57.
29. Xu R., Improvements in particle size analysis using light scattering, in Particle and Surface Characterization Methods, Müller R.H. and Mehnert W., eds., Scientific Publishers, Stuttgart, 1997, 27.
30. Freitas C. and Müller R.H., Spray-drying of solid lipid nanoparticles (SLN), Eur. J. Pharm. Biopharm., 46, 145, 1998.
31. Freitas C. and Müller R.H., Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions, Int. J. Pharm., 168, 221, 1998.
32. Freitas C. and Müller R.H., Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase, Eur. J. Pharm. Biopharm., 47, 125, 1999.
33. Freitas C. and Müller R.H., Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte, J. Microencapsulation, 16, 59, 1999.
34. Jenning V., Mäder K., and Gohla S.H., Solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids: a 1H-NMR study, Int. J. Pharm., 205, 15, 2000.
35. Jenning V., Schäfer-Korting M., and Gohla S., Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties, J. Control. Rel., 66, 115, 2000.
36. Wang J.-X., Sund X., and Zhang, Z.R., Enhanced brain targeting by synthesis of 3,5-dioctanoyl-5-fluoro-2-deoxyuridine and incorporation into solid lipid nanoparticles, Eur. J. Pharm. Biopharm., 54, 285, 2002.
37. Jores K., Mehnert W., and Mäder K., Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study, Pharm. Res., 20, 1274, 2003.
38. Reithmeier H., Herrmann J., and Göpferich A., Lipid microparticles as parenteral controlled release device for peptides, J. Control. Rel., 73, 339, 2001.
39. Reithmeier H., Herrmann J., and Göpferich A., Development and characterization of lipid microparticles as a drug carrier for somatostatin, Int. J. Pharm., 218, 133, 2001.
40. Washington C., Electrical zone sensing, in Particle Size Analysis in Pharmaceutics and Other Industries, Ellis Horwood, New York, 1992, 79.
41. Savolainen M. et al., Evaluation of controlled-release polar lipid microparticles, Int. J. Pharm., 244, 151, 2002.
42. Cortesi R. et al., Production of lipospheres as carriers for bioactive compounds, Biomaterials, 23, 2283, 2002.
43. Hunter R.J., Electrokinetics of particles, in Encyclopedia of Surface and Colloid Science, Hubbard, A.T., ed., Marcel Dekker, New York, 2002, 1907.
44. Zimmermann E. and Müller R.H., Electrolyte-and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media, Eur. J. Pharm. Biopharm., 52, 203, 2001.
45. Cavalli R. et al., Albumin adsorption on stealth and non-stealth solid lipid nanoparticles, S.T.P. Pharm. Sci., 9, 183, 1999.
46. Zara G.P., Intravenous administration to rabbits of non-stealth and stealth doxorubicin loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues, J. Drug Targeting, 10, 327, 2002.
47. Bocca C. et al., Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles, Int. J. Pharm., 175, 185, 1998.
48. Westesen K. and Siekmann B., Investigation of the gel formation of phospholipid stabilized solid lipid nanoparticles, Int. J. Pharm., 151, 35, 1997.
49. Lim S.-J. and Kim C.-K., Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid, Int. J. Pharm., 243, 135, 2002.
50. Trotta M., Debernardi F., and Caputo O., Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique, Int. J. Pharm., 257, 153, 2003.
51. Pinto J.F. and Müller R.H., Pellets as carriers of solid lipid nanoparticles (SLN) for oral administration of drugs, Pharmazie, 54, 506, 1999.
52. Cavalli R. et al., Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles, Int. J. Pharm., 148, 47, 1997.
53. Cui Z.R. and Mumper R.J., Topical immunization using nanoengineered genetic vaccines, J. Conrol. Rel., 81, 173, 2002.
54. Olbrich C. et al., Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA, J. Control. Rel., 77, 345, 2001.
55. Yang, S.C. et al., Body distribution of camptothecin solid lipid nanoparticles after oral administration, Pharm. Res., 16, 751, 1999.
56. Miglietta A. et al., Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporation doxorubicin or paclitaxel, Int. J. Pharm., 210, 61, 2000.
57. Bargoni A. et al., Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. II. Tissue distribution. Pharmacol. Res., 43, 497, 2001.
58. Zara G.P. et al., Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats, J. Pharm. Sci., 91, 1324, 2002.
59. Olbrich C. et al., Stable biocompatible adjuvants - a new type of adjuvant based on solid lipid nanoparticles: a study on cytotoxicity, compatibility and efficacy in chicken, ATLA, 30, 443, 2002.
60. Ahlin P. et al., The effect of lipophilicity of spin-labeled compounds on their distribution in solid lipid nanoparticle dispersions studied by electron paramagnetic resonance, J. Pharm. Sci., 92, 58, 2003.
61. Kristl J. et al., Interactions of solid lipid nanoparticles with model membranes and leukocytes studied by EPR, Int. J. Pharm., 256, 133, 2003.
62. Siekmann B. and Westesen K., Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles, Colloids Surf. B, 3, 159, 1994.
63. Westesen K. and Bunjes H., Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix?, Int. J. Pharm., 115, 129, 1995.
64. Bunjes H., Westesen K., and Koch M.H.J., Crystallization tendency and polymorphic transitions in triglyceride nanoparticles, Int. J. Pharm., 129, 159, 1996.
65. Westesen K., Bunjes H., and Koch M.H.J., Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential, J. Controlled Rel. 48, 223, 1997.
66. Bunjes H., Siekmann B., and Westesen K., Emulsions of supercooled melts: a novel drug delivery system, in Submicron Emulsions in Drug Targeting and Delivery, Benita S., ed., Harwood Academic Publishers, Amsterdam, 1998, 175.
67. Bunjes H., Koch M.H.J., and Westesen K., Effects of surfactants on the crystallization and polymorphism of lipid nanoparticles, Prog. Colloid Polym. Sci., 121, 7, 2002.
68. Bunjes H. et al., Incorporation of the model drug ubidecarenone into solid lipid nanoparticles, Pharm. Res., 18, 287, 2001.
69. Garti N. and Sato K., Crystallization and Polymorphism of Fats and Fatty Acids, Marcel Dekker, New York, 1988.
70. Kaneko F., Polymorphism and phase transitions of fatty acids and acylglycerols, in Crystallization Processes in Fats and Lipid Systems, Garti N. and Sato K., eds., Marcel Dekker, New York, 2001, 53-97.
71. Schwarz C. and Mehnert W., Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization, J. Microencapsulation, 16, 205, 1999.
72. zur Mühlen A., Schwarz C., and Mehnert W., Solid lipid nanoparticles (SLN) for controlled drug delivery: drug release and release mechanism, Eur. J. Pharm. Biopharm., 45, 149, 1998.
73. Jenning V. and Gohla S., Comparison of wax and glyceride solid lipid nanoparticles (SLN), Int. J. Pharm., 196, 219, 2000.
74. Cavalli R. et al., Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with b-cyclodextrins, Int. J. Pharm., 182, 59, 1999.
75. Ford J.L. and Timmins P., Pharmaceutical Thermal Analysis: Techniques and Applications, Ellis Horwood, Chichester, 1989.
76. Giron D., Thermal analysis of drugs and drug products, in Encyclopedia of Pharmaceutical Technology, Vol. 3, Swarbrick J. and Boylan J.C., eds., Marcel Dekker, New York, 2002, 2766.
77. de Vringer T. and de Ronde H.A.G., Preparation and structure of a water-in-oil cream containing lipid nanoparticles, J. Pharm. Sci., 84, 466, 1995.
78. Olbrich C., Kayser O., and Müller R.H., Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN): effect of surfactants, storage time and crystallinity, Int. J. Pharm., 237, 199, 2002.
79. Wissing S.A. and Müller R.H., The influence of the crystallinity of lipid nanoparticles on their occlusive properties, Int. J. Pharm., 242, 377, 2002.
80. Eldem T., Speiser P., and Altdorfer H., Polymorphic behavior of sprayed lipid micropellets and its evaluation by differential scanning calorimetry and scanning electron microscopy, Pharm. Res., 8, 178, 1991.
81. Jenning V. and Gohla S., Encapsulation of retinoids in solid lipid nanoparticles (SLN), J. Microencapsulation, 18, 149, 2001.
82. Cavalli R. et al., The effect of the components of microemulsions on both size and crystalline structure of solid lipid nanoparticles (SLN) containing a series of model molecules, Pharmazie, 53, 392, 1998.
83. Wissing S.A. and Müller R.H., A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles, Int. J. Cosm. Sci., 23, 233, 2001.
84. Wissing S.A. and Müller R.H., The influence of solid lipid nanoparticles on skin hydration and viscoelasticity: in vivo study, Eur. J. Pharm. Biopharm., 56, 67, 2003.
85. Suryanarayanaran R. and Rastogi S., X-ray powder diffractometry, in Encyclopedia of Pharmaceutical Technology, Vol. 3, Swarbrick J. and Boylan J.C., eds., Marcel Dekker, New York, 2002, 3005.
86. Westesen K., Siekmann, B., and Koch, M.H.J., Investigations on the physical state of lipid nanoparticles by synchrotron radiation x-ray diffraction, Int. J. Pharm., 93, 189, 1993.
87. Aquilano D., Cavalli R., and Gasco M.R., Solid lipospheres obtained from hot microemulsions in the presence of different concentrations of cosurfactant: the crystallization of stearic acid polymorphs, Thermochim. Acta, 230, 29, 1993.
88. Lukowski G. et al., Crystallographic investigation of cetyl palmitate solid lipid nanoparticles, Int. J. Pharm., 196, 201, 2000.
89. Jenning V., Thünemann A.F., and Gohla S.H., Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids, Int. J. Pharm., 199, 167, 2000.
90. Bunjes H., Koch M.H.J., and Westesen K., Influence of emulsifiers on the crystallization of solid lipid nanoparticles, J. Pharm. Sci., 92, 1509, 2003.
91. Bunjes H., Einflussnahme unterschiedlicher Faktoren auf Struktur und Eigenschaften von Nanopartikeln aus festen Triglyceriden. PhD thesis, Friedrich Schiller University of Jena, 1998.
92. Unruh T. et al., Self-assembly of triglyceride nanocrystals in suspension, Langmuir, 18, 1796, 2002.
93. Illing A., Unruh T., and Koch M.H.J., Investigation on particle self-assembly in solid lipid based colloidal drug carrier systems, Pharm. Res., 21, 592, 2004.
94. Ugazio E., Cavalli R., and Gasco M.R., Incorporation of cyclosporin A in solid lipid nanoparticles (SLN), Int. J. Pharm., 241, 341, 2002.
95. Cavalli R., Gasco R.M., and Morel S., Behaviour of timolol incorporated in lipospheres in the presence of a series of phosphate esters, S.T.P. Pharm. Sci., 2, 514, 1992.
96. Chen D.B. et al., In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel, Chem. Pharm. Bull., 49, 1444, 2001.
97. Hu F.Q. et al., Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization, Int. J. Pharm., 239, 121, 2002.
98. Cui Z.R. and Mumper R.J., Coating of cationized protein on engineered nanoparticles results in enhanced immune responses, Int. J. Pharm., 238, 229, 2002.
99. Cui Z.R. and Mumper R.J., Genetic immunization using nanoparticles engineered from microemulsion precursors, Pharm. Res. 19, 939, 2002.
100. Harris J.R., Negative Staining and Cryoelectron Microscopy: The Thin Film Techniques, Bios Scientific, Oxford, 1997.
101. Severs N.J. and Shotton D.M., eds., Rapid Freezing, Freeze Fracture and Deep Etching, Wiley-Liss, New York, 1995.
102. Siekmann B. and Westesen K., Preparation and physicochemical characterization of aqueous dispersions of coenzyme Q10 nanoparticles, Pharm. Res., 12, 201, 1995.
103. Sjöström B. et al., Structures of nanoparticles prepared from oil-in-water-emulsions, Pharm. Res., 12, 39, 1995.
104. Sjöström B., Bergenståhl B., and Kronberg B., A method for the preparation of submicron particles of sparingly water-soluble drugs by precipitation in oil-in-wateremulsions. II. Influence of the emulsifier, the solvent, and the drug substance, J. Pharm. Sci., 82, 584, 1993.
105. Demirel M. et al., Formulation and in vitro-in vivo evaluation of piribedil solid lipid micro-and nanoparticles, J. Microencapsulation, 18, 359, 2001.
106. Amselem S., Domb A.J., and Alving C.R., Lipospheres as vaccine carrier systems: effects of size, charge, and phospholipid composition, Vaccine Res., 1, 383, 1992.
107. zur Mühlen A. et al., Atomic force microscopy studies of solid lipid nanoparticles, Pharm. Res., 13, 1411, 1996.
108. zur Mühlen A. and Mehnert W., Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles, Pharmazie, 53, 552, 1998.
109. Dingler A. et al., Solid lipid nanoparticles (SLN/Lipopearls): a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products, J. Microencapsulation, 16, 751, 1999.
110. Cavalli R. et al., Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin, J. Pharm. Sci., 92, 1085, 2003.
111. Cavalli R. et al., Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin, Int. J. Pharm., 238, 241, 2002.
112. Fundaro A. et al., Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats, Pharmacol. Res., 42, 337, 2000.
113. Yang S.C. et al., Body distribution of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on the brain, J. Control. Rel., 59, 299, 1999.
114. Sznitowska M. et al., Bioavailability of diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits, Eur. J. Pharm. Biopharm., 52, 159, 2001.
115. Mayer C. and Lukowski G., Solid state NMR investigations on nanosized carrier systems, Pharm. Res., 17, 486, 2000.
116. Ahlin P. et al., Influence of spin probe structure on its distribution in SLN dispersions. Int. J. Pharm., 196, 241, 2000.